Problem Endometriosis is an inflammatory disease characterized by the endometrial-like tissue growth outside of the uterine cavity. This ectopic growth leads to hormonal imbalances, systemic inflammation, and debilitating pain during menstruation, sexual intercourse, and bodily functions . Although it affects 10–15% of reproductive age women, there is currently no cure and the diagnosis of this diseases remains a clinical challenge [1]. Current clinical management is limited to hormonal suppression, pain control and surgical excision [2]. Consequently, there is a critical need for non-invasive, targeted therapies that can modulate the immune response and minimize recurrence rates without compromising the patient’s reproductive health.